Hydrogen sulfide (H2S) has emerged as an important gaseous signaling molecule. Currently H2S donors have been proposed to affect angiogenesis, prevent atherosclerosis and limit cardiac infarct size. Endogenously, H2S is generated in the vascular wall during the metabolism of cysteine, through the action of cystathionine γ-lyase (CSE).
The research project by the young scientist Dr. Sofia-Iris Bibli from Goethe University Frankfort tries to explore fundamental regulatory mechanisms of CSE-derived H2S and to apply them to paradigms of atherosclerosis development in vivo and extrapolate the results to human samples. Mechanistically, Dr. Bibli plans to identify the physiological relevance of protein sulfhydration- a post-translational protein modification mediated by H2S. The results of the project that focuses on mapping the impact of H2S on endothelial cell function and the human atherosclerotic plaque ‘sulfhydrome’ is expected to yield scientific breakthroughs relevant to both physiology/pathophysiology and H2S based pharmacotherapy. Dr. Bibli’s project is funded by a start-up grant of the Schering Stiftung as part of its program „BOOST – Young Investigator Fund for Innovative Research Ideas“.
10.1161/CIRCULATIONAHA.118.034757
Download FileUnter den Linden 32-34
10117 Berlin
Telefon: +49 - 30 - 20 62 29 65
Email: info@scheringstiftung.de
Thursday to Monday: 1 pm - 7 pm
Saturday to Sunday: 11 am - 7 pm
free entrance